You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東風股份(601515.SH)擬1.35億元收購首鍵藥包75%股權
格隆匯 09-07 19:00

格隆匯9月7日丨東風股份(601515.SH)公佈,公司與唐光文、重慶市康慧恆企業管理中心(有限合夥)及重慶首鍵藥用包裝材料有限公司簽署《關於收購重慶首鍵藥用包裝材料有限公司75%股權之股權轉讓協議》,以人民幣1.35億元的價格受讓唐光文持有的重慶首鍵藥用包裝材料有限公司75%股權。

藥品包裝(包括直接接觸藥品的一級內包裝)是印刷包裝行業的細分領域,作為最大的新興醫藥市場體,伴隨着經濟的持續高速增長,我國醫藥產業近年來增長較快。

公司本次擬同時收購首鍵藥包75%股權及常州市華健藥用包裝材料有限公司(以下簡稱“華健藥包”)70%股權,並實現對兩家公司的控股,首鍵藥包及華健藥包均為原新三板掛牌企業,在行業內具備較強的規模及實力。首鍵藥包主要從事I類醫藥用瓶蓋研發、生產、銷售,主要產品包括口服液、輸液瓶用易刺鋁蓋、鋁塑組合蓋和撕拉鋁蓋等產品,華健藥包主要生產I類藥用包裝鋁箔、SP複合膜、成型衝壓複合硬片(冷衝壓成型鋁、熱帶泡罩鋁)材料,兩者與千葉藥包在產品品類上相互補充,進一步拓展公司醫藥包裝業務的產品類別,並通過千葉藥包、首鍵藥包及華健藥包在生產、銷售及客户資源上的有效協同,有望進一步做強做大公司的醫藥包裝業務板塊,提升公司印刷包裝產業板塊的整體規模及市場競爭力,加快推進“大包裝與大消費產業雙輪驅動發展”戰略的實施。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account